Overview
Mark Zalupski is an Oncologist in Ann Arbor, Michigan. Dr. Zalupski has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is currently accepting new patients.
His clinical research consists of co-authoring 56 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles and participated in 1 clinical trial in the study of Cholangiocarcinoma (Bile Duct Cancer).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Regents Of The University Of Michigan
Vaibhav Sahai is an Oncologist and a Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Sahai is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor. Dr. Sahai is currently accepting new patients.
Henry Ford Health System
Philip Philip is an Oncologist and a Hematologist in West Bloomfield, Michigan. Dr. Philip is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Liver Embolization. Dr. Philip is currently accepting new patients.
Regents Of The University Of Michigan
Thomas Enzler is an Oncologist in Brighton, Michigan. Dr. Enzler is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Stomach Cancer. Dr. Enzler is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cholangiocarcinoma (Bile Duct Cancer)
- Pancreatic CancerDr. Zalupski isElite. Learn about Pancreatic Cancer.
- Distinguished
- Ampullary CancerDr. Zalupski isDistinguished. Learn about Ampullary Cancer.
- Anal CancerDr. Zalupski isDistinguished. Learn about Anal Cancer.
- Familial Colorectal CancerDr. Zalupski isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Zalupski isDistinguished. Learn about Familial Pancreatic Cancer.
- Neuroendocrine TumorDr. Zalupski isDistinguished. Learn about Neuroendocrine Tumor.
- Pancreatic Ductal AdenocarcinomaDr. Zalupski isDistinguished. Learn about Pancreatic Ductal Adenocarcinoma.
- Advanced
- AgranulocytosisDr. Zalupski isAdvanced. Learn about Agranulocytosis.
- Colorectal CancerDr. Zalupski isAdvanced. Learn about Colorectal Cancer.
- Fibrolamellar CarcinomaDr. Zalupski isAdvanced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Zalupski isAdvanced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Zalupski isAdvanced. Learn about Gallbladder Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Experienced
- Adult Soft Tissue SarcomaDr. Zalupski isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Zalupski isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Zalupski isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Appendix CancerDr. Zalupski isExperienced. Learn about Appendix Cancer.
- Bone TumorDr. Zalupski isExperienced. Learn about Bone Tumor.
- ChordomaDr. Zalupski isExperienced. Learn about Chordoma.